[Coagulo-fibrinolytic response to intranasal administration of low dose desmopressin acetate (DDAVP) in normal and hemophiliac subjects]. 1982

E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D003894 Deamino Arginine Vasopressin A synthetic analog of the pituitary hormone, ARGININE VASOPRESSIN. Its action is mediated by the VASOPRESSIN receptor V2. It has prolonged antidiuretic activity, but little pressor effects. It also modulates levels of circulating FACTOR VIII and VON WILLEBRAND FACTOR. Desmopressin,Vasopressin, Deamino Arginine,1-Deamino-8-D-arginine Vasopressin,1-Desamino-8-arginine Vasopressin,Adiuretin,Adiuretin SD,Apo-Desmopressin,DDAVP,Desmogalen,Desmopressin Acetate,Desmopressin Monoacetate,Desmopressin Monoacetate, Trihydrate,Desmopressine Ferring,Desmospray,Desmotabs,Minirin,Minurin,Nocutil,Octim,Octostim,Acetate, Desmopressin,Arginine Vasopressin, Deamino,Ferring, Desmopressine,Monoacetate, Desmopressin,Monoacetate, Trihydrate Desmopressin,Trihydrate Desmopressin Monoacetate,Vasopressin, 1-Deamino-8-D-arginine,Vasopressin, 1-Desamino-8-arginine
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006467 Hemophilia A The classic hemophilia resulting from a deficiency of factor VIII. It is an inherited disorder of blood coagulation characterized by a permanent tendency to hemorrhage. Factor VIII Deficiency,Hemophilia,Autosomal Hemophilia A,Classic Hemophilia,Deficiency, Factor VIII,Factor 8 Deficiency, Congenital,Factor VIII Deficiency, Congenital,Haemophilia,Hemophilia A, Congenital,Hemophilia, Classic,As, Autosomal Hemophilia,Autosomal Hemophilia As,Classic Hemophilias,Congenital Hemophilia A,Congenital Hemophilia As,Hemophilia A, Autosomal,Hemophilia As,Hemophilia As, Autosomal,Hemophilia As, Congenital,Hemophilias, Classic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000281 Administration, Intranasal Delivery of medications through the nasal mucosa. Drug Administration, Intranasal,Administration, Intranasal Drug,Administration, Nasal,Intranasal Administration,Intranasal Drug Administration,Administrations, Intranasal,Administrations, Intranasal Drug,Administrations, Nasal,Drug Administrations, Intranasal,Intranasal Administrations,Intranasal Drug Administrations,Nasal Administration,Nasal Administrations
D001127 Arginine Vasopressin The predominant form of mammalian antidiuretic hormone. It is a nonapeptide containing an ARGININE at residue 8 and two disulfide-linked cysteines at residues of 1 and 6. Arg-vasopressin is used to treat DIABETES INSIPIDUS or to improve vasomotor tone and BLOOD PRESSURE. Argipressin,Vasopressin, Arginine,Arg-Vasopressin,Argipressin Tannate,Arg Vasopressin

Related Publications

E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
June 1980, Thrombosis research,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
January 1997, Nephron,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
December 1989, Thrombosis research,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
July 1991, European heart journal,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
January 2005, Pediatric blood & cancer,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
July 1982, Scandinavian journal of haematology,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
May 1980, British medical journal,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
October 1978, JAMA,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
March 1996, Revista clinica espanola,
E Kakishita, and M Uomoto, and K Nishida, and M Hara, and K Nagai
January 1981, Thrombosis research,
Copied contents to your clipboard!